TNBC is a subtype of breast cancer that estrogen receptors (ERs), progesterone receptors (PRs) and HER-2 are absent and accounts for approximately 15%–20% of all breast cancers (Brenton et al., 2005). This evidence concerns the gene ERBB2 and breast cancer.